Knapp A B, Maguire W, Keren G, Karmen A, Levitt B, Miura D S, Somberg J C
Ann Intern Med. 1983 Feb;98(2):174-7. doi: 10.7326/0003-4819-98-2-174.
Lidocaine is a widely used antiarrhythmic agent whose plasma clearance varies with changes in hepatic blood flow. Cimetidine, an H2-receptor antagonist, has been shown to decrease hepatic blood flow. To ascertain whether cimetidine affected serum lidocaine concentration, we studied 21 patients receiving lidocaine infusions and divided them into two groups. Fifteen patients received cimetidine, 300 mg every 6 hours, in addition to lidocaine; six patients received only lidocaine. In 14 of the 15 patients receiving both lidocaine and cimetidine, a rise in serum lidocaine levels was seen, whereas no change was noted in the control group. Six of the 15 patients were found to have levels in the toxic range and two had symptoms. An additional three patients on lidocaine received diphenhydramine, an H1-receptor antagonist. No elevation in serum lidocaine levels was noted after administration of diphenhydramine. We conclude that there exists an interaction between lidocaine and cimetidine and that the rise in serum lidocaine levels may be mediated by cimetidine's inhibition of the H2 receptor.
利多卡因是一种广泛使用的抗心律失常药物,其血浆清除率随肝血流量的变化而变化。西咪替丁是一种H2受体拮抗剂,已被证明可减少肝血流量。为了确定西咪替丁是否会影响血清利多卡因浓度,我们对21名接受利多卡因输注的患者进行了研究,并将他们分为两组。15名患者在接受利多卡因的同时,每6小时额外接受300毫克西咪替丁;6名患者仅接受利多卡因。在接受利多卡因和西咪替丁的15名患者中,有14名患者的血清利多卡因水平升高,而对照组未观察到变化。15名患者中有6名被发现处于中毒范围,2名有症状。另外3名接受利多卡因治疗的患者服用了H1受体拮抗剂苯海拉明。服用苯海拉明后,血清利多卡因水平未升高。我们得出结论,利多卡因和西咪替丁之间存在相互作用,血清利多卡因水平的升高可能是由西咪替丁对H2受体的抑制作用介导的。